| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 693547 | 2-Amino-4-(2-hydroxy-4-methylphenyl)-5-phenylpyrimidine | 0.00662388971299138 | 0.36202809 |
| NSC 694269 | Benzimidazo[1,2-a][1,8]naphthyridin-7-ium, 6-cyano-5-[[2-(3-methoxyphenyl)ethyl]amino]- 7-methyl-, 4-methylbenzenesulfonate | 0.00662388971299138 | 0.44352751 |
| NSC 697194 | Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dimethoxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- | 0.00662388971299138 | 0.38575598 |
| NSC 724448 | Null | 0.00662388971299138 | 0.26664493 |
| NSC 724955 | 6-Ethylmercapto-4-(2'-thienylidine amino)pyrazolo[3,4-d]pyrimidine | 0.00662388971299138 | -0.11571321 |
| NSC 727048 | 11-(3'-Methylaminopropylidene]-5,6-dihydro-5-keto-2,3-dimeth oxy-6-methyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinolin e | 0.00662388971299138 | 0.48398609 |
| NSC 734307 | 3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide | 0.00662388971299138 | 0.35933562 |
| NSC 407809 | Card-20(22)-enolide, 3-[(6-O-.beta.-D-glucopyranosyl-.beta.-D-glucopyranosyl)oxy]-14-hydroxy-, (3.beta.,5.alpha.)- (9CI) | 0.00663743932906076 | 0.23928902 |
| NSC 174121 | Methotrexate Derivative | 0.00744479268267742 | 0.70665718 |
| NSC 647638 | 1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) | 0.00744479268267742 | -0.0087050852 |